- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01678274
Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection. (TSCORII)
Prospective Characterization of the Heart, Aorta and Blood Pressure in Women With Turner Syndrome. Association With Aortic Dissection.
Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, hypertension, stroke and autoimmune diseases in general.
Our study aim is:
- Using MRI to further characterize and find risk factors leading to aortic dilation.
- Using MRI to assess the degree of aortic distensibility.
- Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.
- Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.
Study Overview
Status
Detailed Description
Turner syndrome is a congenital complete or partial lack one of the female sex chromosomes affecting 1 of 2000 live born girls. The syndrome is characterized by an increased prevalence of ischemic heart disease, aortic dilation and dissection, congenital heart defects, hypertension, stroke, ovarian failure, infertility, decreased final height and autoimmune diseases in general
Our study aim is:
- Using MRI to further characterize and find risk factors leading to aortic dilation.
- Using MRI to describe aortic dimensions
- Using MRI to assess the degree of aortic distensibility.
- Using Computed tomography x-ray scanning of the heart and coronary arteries to characterize the prevalence and degree of ischemic heart disease and coronary anomalies.
- Using pressure sensitive ultrasound (applanation tonometry) to assess the degree of aortic stiffness when compared to controls using end points as Pulse Wave Velocity, Augmentation Index and Central Pulse Pressure.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Aarhus, Denmark, 8000
- Department of Endocrinology and Internal Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Females with Turner Syndrome previously participating in our study number 2001024 are recruited from out-patient clinics.
Controls are healthy volunteers recruited from the general population by advertisement.
Description
Inclusion Criteria with respect to individuals acting as controls:
- Healthy age matched females
Exclusion Criteria:
- Contraindications for MRI
- Contraindications for CT
- Severe obesity
- Acute og Chronic disease with known or presumed significance with concern to outcomes of the study
- Previous or present malignant disease
- Clinically significant liver disease
- Mechanic or biological heart valves
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Turner syndrome
Females with Turner syndrome
|
Control group
age matched females acting as controls
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aortic dimensions
Time Frame: Once
|
Aortic dimensions measured by MRI
|
Once
|
Agatston score
Time Frame: Once
|
Coronary CT evaluation of Agatston score
|
Once
|
Segment involvement score
Time Frame: Once
|
Segment involvement score (SIS) calculated as the sum of segments with one or more coronary plaques (score 0-18).
|
Once
|
Aortic distensibility
Time Frame: Once
|
Aortic distensibillity as measured by MRI
|
Once
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24 hour blood pressure
Time Frame: 24 hour
|
24 hour blood pressure
|
24 hour
|
Pulse Wave Velocity
Time Frame: Once
|
Pulse Wave Velocity measured by applanation tonometry.
|
Once
|
Augmentation index
Time Frame: Once
|
Augmentation index measured by applanation tonometry.
|
Once
|
Central blood pressure
Time Frame: Once
|
Central blood pressure measured by applanation tonometry.
|
Once
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
echocardiography
Time Frame: Once
|
echocardiography evaluating Mitral and aortic valves, left ventricular hypertrophy, diastolic and systolic function etc..
|
Once
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Claus H Gravholt, MD, Aarhus University Hospital
Publications and helpful links
General Publications
- Viuff MH, Just J, Brun S, Dam TV, Hansen M, Melgaard L, Hougaard DM, Lappe M, Gravholt CH. Women With Turner Syndrome Are Both Estrogen and Androgen Deficient: The Impact of Hormone Replacement Therapy. J Clin Endocrinol Metab. 2022 Jun 16;107(7):1983-1993. doi: 10.1210/clinem/dgac167.
- Wen J, Trolle C, Viuff MH, Ringgaard S, Laugesen E, Gutmark EJ, Subramaniam DR, Backeljauw P, Gutmark-Little I, Andersen NH, Mortensen KH, Gravholt CH. Impaired aortic distensibility and elevated central blood pressure in Turner Syndrome: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2018 Dec 13;20(1):80. doi: 10.1186/s12968-018-0497-0.
- Subramaniam DR, Stoddard WA, Mortensen KH, Ringgaard S, Trolle C, Gravholt CH, Gutmark EJ, Mylavarapu G, Backeljauw PF, Gutmark-Little I. Continuous measurement of aortic dimensions in Turner syndrome: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2017 Feb 24;19(1):20. doi: 10.1186/s12968-017-0336-8.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Endocrine System Diseases
- Disease
- Gonadal Disorders
- Disorders of Sex Development
- Urogenital Abnormalities
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Coronary Disease
- Cardiovascular Abnormalities
- Chromosome Disorders
- Sex Chromosome Disorders
- Aortic Diseases
- Sex Chromosome Disorders of Sex Development
- Heart Diseases
- Coronary Artery Disease
- Myocardial Ischemia
- Hypertension
- Syndrome
- Heart Defects, Congenital
- Aneurysm
- Aneurysm, Dissecting
- Aortic Aneurysm
- Turner Syndrome
- Gonadal Dysgenesis
Other Study ID Numbers
- 35202
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
Addpharma Inc.Completed
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Istituto Auxologico ItalianoRecruitingHypertension,Essential | Hypertension, UncontrolledArgentina, China